Interim results of fight-202, a phase II, open-label, multicenter study of INCB054828 in patients (pts) with previously treated advanced/metastatic or surgically unresectable cholangiocarcinoma (CCA) with/without fibroblast growth factor (FGF)/FGF receptor (FGFR) genetic alterations

A. Hollebecque; M. Borad; V. Sahai; D. V.T. Catenacci; A. Murphy; G. Vaccaro; A. Paulson; D. Y. Oh; L. Féliz; C. Lihou; H. Zhen; G. K. Abou-Alfa

doi:10.1093/annonc/mdy282.139

Interim results of fight-202, a phase II, open-label, multicenter study of INCB054828 in patients (pts) with previously treated advanced/metastatic or surgically unresectable cholangiocarcinoma (CCA) with/without fibroblast growth factor (FGF)/FGF receptor (FGFR) genetic alterations

A. Hollebecque, M. Borad, V. Sahai, D. V.T. Catenacci, A. Murphy, G. Vaccaro, A. Paulson, D. Y. Oh, L. Féliz, C. Lihou, H. Zhen, G. K. Abou-Alfa

Hematology/Oncology

Research output: Contribution to journal › Article › peer-review

Original language	English (US)
Pages (from-to)	viii258
Journal	Annals of oncology : official journal of the European Society for Medical Oncology
Volume	29
DOIs	https://doi.org/10.1093/annonc/mdy282.139
State	Published - Oct 1 2018

ASJC Scopus subject areas

Hematology
Oncology

Access to Document

10.1093/annonc/mdy282.139

Cite this

Hollebecque, A., Borad, M., Sahai, V., Catenacci, D. V. T., Murphy, A., Vaccaro, G., Paulson, A., Oh, D. Y., Féliz, L., Lihou, C., Zhen, H., & Abou-Alfa, G. K. (2018). Interim results of fight-202, a phase II, open-label, multicenter study of INCB054828 in patients (pts) with previously treated advanced/metastatic or surgically unresectable cholangiocarcinoma (CCA) with/without fibroblast growth factor (FGF)/FGF receptor (FGFR) genetic alterations. Annals of oncology : official journal of the European Society for Medical Oncology, 29, viii258. https://doi.org/10.1093/annonc/mdy282.139

Interim results of fight-202, a phase II, open-label, multicenter study of INCB054828 in patients (pts) with previously treated advanced/metastatic or surgically unresectable cholangiocarcinoma (CCA) with/without fibroblast growth factor (FGF)/FGF receptor (FGFR) genetic alterations. / Hollebecque, A.; Borad, M.; Sahai, V. et al.
In: Annals of oncology : official journal of the European Society for Medical Oncology, Vol. 29, 01.10.2018, p. viii258.

Research output: Contribution to journal › Article › peer-review

Hollebecque, A, Borad, M, Sahai, V, Catenacci, DVT, Murphy, A, Vaccaro, G, Paulson, A, Oh, DY, Féliz, L, Lihou, C, Zhen, H & Abou-Alfa, GK 2018, 'Interim results of fight-202, a phase II, open-label, multicenter study of INCB054828 in patients (pts) with previously treated advanced/metastatic or surgically unresectable cholangiocarcinoma (CCA) with/without fibroblast growth factor (FGF)/FGF receptor (FGFR) genetic alterations', Annals of oncology : official journal of the European Society for Medical Oncology, vol. 29, pp. viii258. https://doi.org/10.1093/annonc/mdy282.139

Hollebecque A, Borad M, Sahai V, Catenacci DVT, Murphy A, Vaccaro G et al. Interim results of fight-202, a phase II, open-label, multicenter study of INCB054828 in patients (pts) with previously treated advanced/metastatic or surgically unresectable cholangiocarcinoma (CCA) with/without fibroblast growth factor (FGF)/FGF receptor (FGFR) genetic alterations. Annals of oncology : official journal of the European Society for Medical Oncology. 2018 Oct 1;29:viii258. doi: 10.1093/annonc/mdy282.139

Hollebecque, A. ; Borad, M. ; Sahai, V. et al. / Interim results of fight-202, a phase II, open-label, multicenter study of INCB054828 in patients (pts) with previously treated advanced/metastatic or surgically unresectable cholangiocarcinoma (CCA) with/without fibroblast growth factor (FGF)/FGF receptor (FGFR) genetic alterations. In: Annals of oncology : official journal of the European Society for Medical Oncology. 2018 ; Vol. 29. pp. viii258.

@article{1ac8f4bdb41345759c4a708e413fbece,

title = "Interim results of fight-202, a phase II, open-label, multicenter study of INCB054828 in patients (pts) with previously treated advanced/metastatic or surgically unresectable cholangiocarcinoma (CCA) with/without fibroblast growth factor (FGF)/FGF receptor (FGFR) genetic alterations",

author = "A. Hollebecque and M. Borad and V. Sahai and Catenacci, {D. V.T.} and A. Murphy and G. Vaccaro and A. Paulson and Oh, {D. Y.} and L. F{\'e}liz and C. Lihou and H. Zhen and Abou-Alfa, {G. K.}",

year = "2018",

month = oct,

day = "1",

doi = "10.1093/annonc/mdy282.139",

language = "English (US)",

volume = "29",

pages = "viii258",

journal = "Annals of oncology : official journal of the European Society for Medical Oncology",

issn = "0923-7534",

publisher = "Oxford University Press",

}

TY - JOUR

T1 - Interim results of fight-202, a phase II, open-label, multicenter study of INCB054828 in patients (pts) with previously treated advanced/metastatic or surgically unresectable cholangiocarcinoma (CCA) with/without fibroblast growth factor (FGF)/FGF receptor (FGFR) genetic alterations

AU - Hollebecque, A.

AU - Borad, M.

AU - Sahai, V.

AU - Catenacci, D. V.T.

AU - Murphy, A.

AU - Vaccaro, G.

AU - Paulson, A.

AU - Oh, D. Y.

AU - Féliz, L.

AU - Lihou, C.

AU - Zhen, H.

AU - Abou-Alfa, G. K.

PY - 2018/10/1

Y1 - 2018/10/1

UR - http://www.scopus.com/inward/record.url?scp=85079401053&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85079401053&partnerID=8YFLogxK

U2 - 10.1093/annonc/mdy282.139

DO - 10.1093/annonc/mdy282.139

M3 - Article

C2 - 32136580

SN - 0923-7534

VL - 29

SP - viii258

JO - Annals of oncology : official journal of the European Society for Medical Oncology

JF - Annals of oncology : official journal of the European Society for Medical Oncology

ER -

Interim results of fight-202, a phase II, open-label, multicenter study of INCB054828 in patients (pts) with previously treated advanced/metastatic or surgically unresectable cholangiocarcinoma (CCA) with/without fibroblast growth factor (FGF)/FGF receptor (FGFR) genetic alterations

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this